A team of researchers and entrepreneurs from the Israeli company Betalin Therapeutics claim to have a cure for diabetes, suffering from millions of people around the world. The remedy could get you to the market in the next few years.
The company has developed the first bioartificial pancreas, lung tissue, and insulin secreting cells.
The artificial pancreas would be implanted in the patient and would connect to the blood vessels, and could measure the sugar level of the body and secrete the optimal amount of insulin needed to balance the sugar in the blood, explains The Jerusalem Post daily.
"Today, there are only ways to control the disease. But they are healing. The diabetic pancreas has lost the function of secreting insulin and if we return it. The patient should not be injected with insulin in his body," Dr. Nikolai Kunicher, Executive Director, quoted by the media.
According to Kunicher, the team has completed a series with animals. Clinical trials in humans are expected to begin in the next 12 months.
The company estimates that the biological pancreas will cost around $ 50,000 per patient.
According to the World Health Organization, there is an average billion people around the world who suffer from Type I or Type II diabetes. Between them, according to Kunicher, some 160 million depend on insulin.
Nobel laureate in chemistry in 1989, Sidney Altman, considered one of the most important molecular biologists in the world, who also has diabetes, believes that this new approach will have a global impact, he notes daily.